234 Matching Annotations
  1. Last 7 days
    1. PatientID: 161

      KindredID: 62

      Case: F, 41Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The patient's daughter presented with a CNS hemangioblastoma and multiple pancreatic cysts and tumors at the age of 14.

      CasePresentingHPOs: HP:0005584; HP:0002666; HP:0010797; HP:0001737; HP:0001732 (Renal cell carcinoma, Pheochromocytoma, Hemangioblastoma, Pancreatic cysts, Abnormality of the pancreas)

      CaseHPOFreeText: The proband presented with a CNS hemangioblastoma at age 28, and a renal cell carcinoma, multiple pancreatic cysts/tumors, and a pheochromocytoma at age 41.

      CaseNotHPOs: HP:0009711 (Retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This cohort was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.R161* (c.481C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2217, https://www.ncbi.nlm.nih.gov/clinvar/variation/2217/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R161* (c.481C>T)

      MultipleGeneVariants: N/A

    2. PatientID: 179

      KindredID: 70

      Case: F, 44Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband (patient 179) had a daughter (patient 180) who was confirmed with the mutation, and present4ed with a retinal angioma and multiple pancreatic cysts/tumors at 17. The proband also has three family members who were unconfirmed with the mutation (passed away before diagnosis): patient 181 (proband's brother) had a CNS hemangioblastoma at 17, patient 182 (proband's father) had a CNS hemangioblastoma at 49, renal cell carcinoma and multiple pancreatic cysts/tumors at 56, and patient 183 (proband's uncle) had a CNS hemangioblastoma at 32 and a retinal angioma at 30.

      CasePresentingHPOs: HP:0001737; HP:0001732; HP:0005584 (Pancreatic cysts, Abnormality of the pancreas, Renal cell carcinoma)

      CaseHPOFreeText: The proband presented with a renal cell carcinoma at 44, and multiple pancreatic cysts/tumors at 28.

      CaseNotHPOs: HP:0010797; HP:0002666; HP:0009711 (Hemangioblastoma, Pheochromocytoma, Retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.C162* (c.486C>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223226; https://www.ncbi.nlm.nih.gov/clinvar/variation/223226/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: C162* (c.486C>A)

      MultipleGeneVariants: N/A

    3. PatientID: 151

      KindredID: 55

      Case: M, 28Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband (patient 150) has a father (patient 151) who was also confirmed with this germline mutation, and presented at 22 with a CNS hemangioblastoma and 28 with renal cell carcinoma. The proband presented with a CNS hemangioblastoma at 14 and multiple pancreatic cysts/tumors at 17. The proband also has a grandmother (patient 153) who presented with a CNS hemangioblastoma at 43, but who passed away before diagnosis/ genetic testing.

      CasePresentingHPOs: HP:0010797; HP:0005584 (Hemangioblastoma, Renal cell carcinoma)

      CaseHPOFreeText: The proband's father presented with a CNS hemangioblastoma at 22 and renal cell carcinoma at 28.

      CaseNotHPOs: HP:0009711; HP:0002666; HP:0001737; HP:0001732 (Retinal capillary hemangioma, Pheochromocytoma, Pancreatic cysts, Abnormality of the pancreas)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.I151S (c.452T>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223215, https://www.ncbi.nlm.nih.gov/clinvar/variation/223215/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: I151S (c.452T>G)

      MultipleGeneVariants: N/A

    4. PatientID: 138

      KindredID: 52

      Case: M, 28Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband (patient 138) had multiple family members affected with the mutation. Their daughter (pt 139) was asymptomatic at the time of assessment; their son (pt 140) was also asymptomatic at the time of assessment; their mother (pt 141) presented with a CNS hemangioblastoma at 66, renal cell carcinoma at 69, and multiple pancreatic cysts/tumors at 66; their sister 1 (pt 142) presented with a CNS hemangioblastoma at 32, renal cell carcinoma at 36, and multiple pancreatic cysts/tumors at 36; the son of sister 1 was asymptomatic at the time of analysis; the daughter of sister 1 was asymptomatic at the time of analysis; the proband's sister 2 presented at age 39 with CNS hemangioblastoma, renal cell carcinoma, and multiple pancreatic cysts/tumors; and the son of sister 2 was asymptomatic at the time of analysis. All members of this family were genetically confirmed to have this mutation.

      CasePresentingHPOs: HP:0010797, HP:0001737; HP:0001732; HP:0005584 (Hemangioblastoma, Pancreatic cysts, Abnormality of the pancreas, Renal cell carcinoma)

      CaseHPOFreeText: The proband presented at age 28 with a CNS hemangioblastoma, renal cell carcinoma, and multiple pancreatic cysts/tumors.

      CaseNotHPOs: HP:0002666; HP:0009711 (Pheochromocytoma, Retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: c.464-1G>C

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223220; https://www.ncbi.nlm.nih.gov/clinvar/variation/223220/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: splice_site_variant

      CivicName: Splice Site (c.464-1G>C)

      MultipleGeneVariants: N/A

    Tags

    Annotators

    URL

    1. The proband was a 28-year-old male, who presented with an episodic headache for 10 years. Both the finger-nose test and the Romberg's sign were recorded as positive in the physical examination. A cyst and a nodule were revealed via brain MRI (Fig. 2). The cyst was demonstrated to be a hemangioblastoma tumor following surgical excision followed by histopathological analysis of the biopsy tissues. H&E staining revealed that the lesion contained a large number of thin-walled capillaries (Fig. 3). The sole neoplastic element, known as the ‘stromal cell’, inhabited the interstices between ramifying vascular arcades. Stromal cells stained for S-100 and NSE exhibited dense-core intracytoplasmic granules, however did not demonstrate expression of GFAP or EMA (Fig. 3), which has previously been detected immunohistochemically in most nonneoplastic epithelia (18). Stromal cells did not exhibit positive staining for endothelial markers such as CD34, whereas the thin-walled capillaries were positive; stromal cells occasionally exhibited the expression of vascular marker F8 (Fig. 3). The expression of Ki-67, which is a proliferation marker (19), was <1% (Range of normal value 1–2%; Fig. 3). Therefore, the proband was diagnosed with VHL syndrome at the Hunan Cancer Hospital (Changsha, China).

      PatientID: proband (III:2)

      KindredID: 1

      Case: M, 28Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: Two of the proband's maternal cousins were healthy individuals that were demonstrated to carry the same mutation, as revealed by Sanger sequencing: III:4, male, and III:8, female as seen in the pedigree from Figure 1. A further five affected members of the family had previously died from this syndrome, including the proband's mother (II:2), maternal grandfather (I:1), two uncles (II:3 and II:5), and a cousin (III:10). These deceased family members had not previously been tested for mutations in the VHL gene. Pedigree: see Figure 1.

      CasePresentingHPOs: HP:0010797 (Hemangioblastoma)

      CaseHPOFreeText: A cyst and a nodule were revealed via brain MRI. The cyst was demonstrated to be a hemangioblastoma tumor following surgical excision

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: NA

      SupplementalData: NA

      Variant: p.H115Q (c.345C>A)

      ClinVar: 496057 https://www.ncbi.nlm.nih.gov/clinvar/variation/496057/

      CAID:N/A

      gnomAD: N/A

      VariantEvidence: RNA extracted from peripheral blood samples obtained from patients in the pedigree and the healthy controls. No significant difference in the expression of pVHL was demonstrated between the mutated and wild type cDNA, as demonstrated by RT-sqPCR analysis.

      MutationType: missense_variant;transversion

      CivicName: H115Q (c.345C>A)

      MultipleGeneVariants: N/A

    1. Sixteen patients were screened for variants in one or more of the RCC predisposition genes VHL, FH, FLCN, MET or SDHB (Table 2). No pathogenic variants were found in FH, FLCN, MET or SDHB, but we did find a start codon variant (c.3G>A, p.Met1Ile) and a missense variant (c.631A>C, p.Met211Leu) in VHL in a patient from cohort 2 (Fig 3). Both VHL variants are classified as class 3 variants (VUS) according to the classification guidelines from IARC [26].Open in a separate windowFig 3Pedigree of family 6002.The arrow indicates the proband. The age of RCC-onset and histological subtype the renal tumor is listed below the proband (III:3). A start codon VUS (c.3G>A, p.Met1Ile) and a missense variant (c.631A>C, p. Met211Leu) in VHL and a intron variant (c.1729+8T>C) in BAP1 was identified in a peripheral blood sample from the proband. The proband’s maternal uncle (II:1) was diagnosed with testicular cancer.

      PatientID: III:1

      KindredID: 6002

      Case: M, 28Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: Maternal uncle (II:1) had a history of testicular cancer but no genetic data was available.

      CohortInfo: Patients met at least one of the criteria: RCC < forty years of age or bilateral or multifocal RCC < sixty years of age or family history of RCC or three relatives with RCC, melanoma or mesothelioma (at least one case of RCC) or patients diagnosed with RCC and melanoma. Family history of RCC is defined as two or more first-degree relatives with RCC. Patients with a previously identified pathogenic variant in a renal cancer predisposition gene were not included. Patient inclusion took place from February 2014 to January 2015. This patient was grouped in “Group 1” where only one family member was affected by renal cell carcinoma (n=20).

      CasePresentingHPOs: HP:0006770 (Clear cell renal cell carcinoma)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: The patient has been through the national screening program for putative VHL, which includes MRI of the cerebrum, spinal medulla and abdomen, neurological examination, auditory tests, ocular examination and blood work for chromogranin A and metanephrines, with normal results.

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Figure 3

      Variant: p.M1I (c.3G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 135406, https://www.ncbi.nlm.nih.gov/clinvar/variation/135406/

      CAID: N/A

      gnomAD: 0.00007043, https://gnomad.broadinstitute.org/variant/3-10183534-G-A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: M1I (c.3G>A)

      MultipleGeneVariants: Germline, VHL, c.631A>C (p.Met211Leu)

      MultipleGeneVariants: Germline, BAP1, c.1729+8T>C

    1. F28greenFemale28Complete deletion2nd R (1 prior L)No>Yes21.613No

      PatientID: None

      KindredID: 6

      Case: F, 28Y0M, Ethnicity Unknown

      DiseaseAssertion: Clear Cell Renal Cell Carcinoma

      FamilyInfo: N/A

      CohortInfo: The National Cancer Institute has a frozen tumour bank of ccRCC tumours that have been removed from VHL patients. We selected six patients, three males and three females, with at least five tumours from a single surgery from one kidney.

      CasePresentingHPOs: HP:0006770 (clear cell renal cell carcinoma)

      CaseHPOFreeText: The patient presented with ccRCC at age 28.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: Exon 1-3 Loss

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: In the 13 tumours that was sequenced from this patient, 10 had completely lost the other copy of chromosome 3.

      MutationType: exon_loss_variant

      CivicName: Deletion

      MultipleGeneVariants: N/A

    1. 1228Fnt 694 C to T, Arg to stop, exon 3

      PatientID: 12

      KindredID: 6004

      Case: F, 28Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0030405 (pancreatic endocrine tumour)

      CaseHPOFreeText: She presented with one pathologic pancreatic endocrine tumour.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R161* (c.481C>T)

      LegacyVariant: p.R161* (c.694C>T)

      CaseProblemVariantFreeText: N/A

      ClinVar:2217 https://www.ncbi.nlm.nih.gov/clinvar/variation/2217/

      CAID: CA020408 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.481C%3ET

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: R161* (c.481C>T)

      MultipleGeneVariants: N/A

    1. 5

      PatientID: II-3

      KindredID: I

      Case: M, Age Unknown, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: In the patient’s 12 member Chinese family, 7 members were found to carry the NM_000551.3:c.114delC mutation. Five had manifestations of CNS hemangioblastoma, and three of the five were deceased. The other two members found to carry the mutation were asymptomatic, although the paper states that this is likely due to their young age.

      CasePresentingHPOs: HP:0010797 (Hemangioblastoma)

      CaseHPOFreeText: The patient is deceased. The paper implies that the mutation was confirmed through stored tumour tissue.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.G39Afs*28(c.114delC)

      LegacyVariant: p.G39Afs*28(c.327delC)

      ClinVarID: N/A

      CAID: CA2573047816, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_canonicalid?canonicalid=CA2573047816

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift_variant

      CivicName: G39Afs(c.114delC)

      MultipleGeneVariants: N/A

    1. PatientID: Proband 6

      KindredID: 2

      Case: F, 28Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: Mother, aunt and aunt’s cousin (all relative to proband 6) had this variant. Mother and proband presented with unilateral pheochromocytoma and aunt and aunt’s cousin were asymptomatic. Proband also presented with a renal cyst and hypertension.

      CasePresentingHPOs: HP:0002666; HP:0000107; HP:0000822 (Pheochromocytoma, Renal cyst, Hypertension)

      CaseHPOFreeText: Unilateral PCC diagnosed at 28Y and unilateral renal cyst and hypertension. Stated as having VHL type IIC.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R120T (c.359G>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: CA351753738, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.359G%3EC

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: R120T (c.359G>C)

      MultipleGeneVariants: N/A

    1. PMID: 23143947

      PatientID: CIV:1

      KindredID: C

      Case: M, 28Y0M, Chinese

      DiseaseAssertion: hemangioblastoma

      FamilyInfo: A 4-generation family is given with 3 confirmed members with this mutation. 3 other members had VHL-presenations however had not been tested for the gene.

      CasePresentingHPOs: HP:0010797 (hemangioblastoma)

      CaseHPOFreeText: diagnosed with hemangioblastoma and died of surgical complications at the age of 28Y

      CaseNotHPOs: HP:0002666; HP:0005584; HP:0001737; HP:0009711 (pheochromocytoma, renal cell carcinoma, pancreatic cysts, retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.S80I (c.239G>T) [assumed]

      LegacyVariant: p.S80I (c.452G>T)

      CaseProblemVariantFreeText: N/A

      ClinVarID: 625229 https://www.ncbi.nlm.nih.gov/clinvar/variation/625229/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: No genetic testing was done prior to death, however family history and presentation leads to this assumption

      MutationType: missense_variant; transversion

      CivicName: S80I (c.239G>T)

      MultipleGeneVariants: N/A

  2. Nov 2026
    1. PatientID: 277

      KindredID: 108

      Case: M, 28Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband, patient 277, presented with a CNS hemangioblastoma at age 16, retinal angioma a 20, and renal cell carcinoma at 28. Their father who passed away before diagnosis presented with a CNS hemangioblastoma at 48.

      CasePresentingHPOs: HP:0010797; HP:0009711; HP:0005584 (Hemangioblastoma, Retinal capillary hemangioma, Renal cell carcinoma)

      CaseHPOFreeText: The proband, patient 277, presented with a CNS hemangioblastoma at age 16, retinal angioma a 20, and renal cell carcinoma at 28.

      CaseNotHPOs: HP:0002666; HP:0001737; HP:0001732 (Pheochromocytoma, Pancreatic cysts, Abnormality of the pancreas)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This cohort was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: Exon 2-3 Deletion (c.341-?_642+?del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: Exon 2-3 Deletion

      MultipleGeneVariants: N/A

    2. PatientID: 30

      KindredID: 11

      Case: F, 37Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband (patient 30) has a son (patient 31) who was genetically confirmed with the mutation, who was asymptomatic at the time of analysis. She also has a father (patient 32, CNS hemangioblastoma at 42), a brother 1 (patient 33, CNS hemangioblastoma at 28), brother 2 (patient 34, CNS hemangioblastoma at 30), and uncle (patient 35, retinal angioma at 60) who passed away before they could be diagnosed/ genetically confirmed with the mutation.

      CasePresentingHPOs: HP:0009711; HP:0001737; HP:0001732; HP:0005584; HP:0010797 (Retinal capillary hemangioma, Pancreatic cysts, Abnormality of the pancreas, Renal cell carcinoma, Hemangioblastoma)

      CaseHPOFreeText: The proband presented with CNS hemangioblastoma at 28, retinal angioma at 26, renal cell carcinoma at 37, and multiple pancreatic cysts/tumors at 28.

      CaseNotHPOs: HP:0002666 (Pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336). This mutation was also published in PMID 32179488 in reference to one patient with VHL disease type 1 in this paper with the c.227_229del variant. However, it is unclear whether patient #27, #28, or #30 is specifically published in PMID 32179488.

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.F76del (c.227_229del)

      LegacyVariant: F76del (c.224_226delTCT)

      CaseProblemVariantFreeText: The protein coding change for this variant is listed in this paper as p.F76Cfs*138. However the DNA change listed in this paper (c.224_226delTCT) is equivalent to c.227_229delTCT, and results in p.F76del. This variant is entered on CIViC with p.F76del. As a note the latter c. nomenclature is preferred due to the 3' rule.

      ClinVarID: N/A

      CAID: CA357012; https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.224_226del

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: inframe_deletion

      CivicName: F76del (c.224_226delTCT)

      MultipleGeneVariants: N/A

    3. PatientID: 259

      KindredID: 100

      Case: F, 28Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband, patient 259, presented with a CNS hemangioblastoma and multiple pancreatic cysts/tumors at age 28, and a retinal angioma at age 24. The proband's son, patient 260, was asymptomatic at the time of analysis.

      CasePresentingHPOs: N/A

      CasePresentingHPOs: HP:0009711; HP:0001737; HP:0001732; HP:0005584; HP:0010797 (Retinal capillary hemangioma, Pancreatic cysts, Abnormality of the pancreas, Hemangioblastoma)

      CaseHPOFreeText: The proband, patient 259, presented with a CNS hemangioblastoma and multiple pancreatic cysts/tumors at age 28, and a retinal angioma at age 24.

      CaseNotHPOs: HP:0002666; HP:0005584 (Pheochromocytoma, Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This cohort was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: Exon 1-2 Deletion (c.1-?_463+?del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: exon_loss_variant

      CivicName: Exon 1-2 Deletion

      MultipleGeneVariants: N/A

    4. PatientID: 81

      KindredID: 27

      Case: M, 38Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband (patient 81) had 3 family members confirmed with the mutation: his aunt 2 (patient 85) had pancreatic cysts and/or tumors at age 50, his cousin/ the son of Aunt 2 was asymptomatic at the time of assessment, and the granddaughter of aunt 2 was also asymptomatic at the time of assessment. The proband also had 3 family members who passed away before diagnosis/ before confirming the mutation: his mother (patient 82) had a CNS hemangioblastoma at 33, his Aunt 1 (patient 83) had a CNS hemangioblastoma at 32, and his cousin/ the son of Aunt 1 (patient 84) had a CNS hemangioblastoma at 30.

      CasePresentingHPOs: HP:0010797; HP:0001732; HP:0001737; HP:0005584; HP:0002666 (Hemangioblastoma, Abnormality of the pancreas, Pancreatic cysts, Renal cell carcinoma, Pheochromocytoma)

      CaseHPOFreeText: The proband presented with CNS hemangioblastoma at age 28, and renal cell carcinoma, multiple pancreatic cysts/tumors, and pheochromocytoma at age 38.

      CaseNotHPOs: HP:0009711(Retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.N90I (c.269A>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223172; https://www.ncbi.nlm.nih.gov/clinvar/variation/223172/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: N90I (c.269A>T)

      MultipleGeneVariants: N/A

    5. PatientID: 71

      KindredID: 25

      Case: F, 30Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband has the same mutation as her son (patient no.72). Her son did not present with hemangioblastoma, multiple pancreatic cysts/tumors, retinal angioma, renal cell carcinoma, or pheochromocytoma, and is apparently asymptomatic.

      CasePresentingHPOs: HP:0010797; HP:0005584; HP:0001737; HP:0001732 (Hemangioblastoma, Renal cell carcinoma, Pancreatic cysts, Abnormality of the pancreas)

      CaseHPOFreeText: The patient presented with renal cell carcinoma at age 28, multiple pancreatic cysts/tumors at age 28, and hemangioblastoma at age 30.

      CaseNotHPOs: HP:0009711; HP:0002666 (Retinal capillary hemangioma, Pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This cohort was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.W88* (c.263G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 182978, https://www.ncbi.nlm.nih.gov/clinvar/variation/182978/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: W88* (c.263G>A)

      MultipleGeneVariants: N/A

    Tags

    Annotators

    URL

    1. (c.233A>G [p.Asn78Ser]

      PatientID: 5

      KindredID: 5

      Case: 28Y0M, Sex unknown, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: None

      CasePresentingHPOs:  HP:0010797; HP:0005584 (hemangioblastoma, renal cell carcinoma)

      CaseHPOFreeText: CNS hemangioblastoma first presenting at age 28Y and RCC at age 28Y

      CaseNotHPOs: HP:0009715; HP:0002666 (Papillary cystadenoma of the epididymis, pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.N78S (c.233A>G)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 93326 https://www.ncbi.nlm.nih.gov/clinvar/variation/93326/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transition

      CivicName: N78S (c.233A>G)

      MultipleGeneVariants: N/A

    1. The proband (III-4) was a 28-year-old male who consulted because of a history of VHL disease in his family. The mother (II-1) developed cerebellar, medullar and bilateral retinal HBs; two maternal aunts (II-2 and II-3) were affected by retinal and CNS HBs and unspecified renal tumours, whereas his grandfather (I-2) had unspecified abdominal tumours. All these relatives died in their early 30s (Table 1). Magnetic resonance (MR) imaging of brain and spine was performed in this subject demonstrating cerebellar HB. Ophthalmologic examination revealed VA of 6/6 in both eyes, and IOP of 14 mmHg in the right eye and of 18 mmHg in the left eye. No anomalies were found at biomicroscopic inspection; funduscopic evaluation of the right eye showed a well defined orange-red mass corresponding to a peripheral retinal HB of approximately 1 disc diameter associated with a prominent feeding artery and to a draining vein. FAG demonstrated hyperfluorescence of this retinal angioma as well as enlargement and tortuosity of retinal blood vessels.

      PatientID: III-4 (Proband)

      KindredID: 1

      Case: M, 28Y0M, Mexican

      DiseaseAssertion: VHL

      FamilyInfo: Family composed of six affected individuals and three diseased subjects (III-2, III-3, III-4) were studied. III-4 (proband) presented with a CNS hemangioblastoma and a retinal hemangioblastoma. The mother (II-1) developed cerebellar, medullar and bilateral retinal HBs; two maternal aunts (II-2 and II-3) were affected by retinal and CNS HBs and unspecified renal tumors, whereas his grandfather (I-2) had unspecified abdominal tumors. All these relatives died in their early 30s. A 35-year-old sister (III-2) demonstrated cerebellar HB, right eye retinal HB and renal cell carcinoma, whereas a 32-year-old brother (III-3) presented with cerebellar HB, right eye retinal HB, renal cell carcinoma and pheochromocytoma. A mutation-carrier nephew (IV-2) presented only atrophy of the retinal pigment epithelium. All of these family members were found to have the R82P (c.245G>C) germline VHL variant. Eighteen additional healthy relatives were analyzed and tested negative for the mutation.

      CohortInfo: Two families and one apparently non-familial case were studied at the Institute of Ophthalmology ‘Conde de Valenciana’ (Mexico City, Mexico).

      CasePresentingHPOs: HP:0010797; HP:0009711 (Hemangioblastoma, Retinal capillary hemangioma)

      CaseHPOFreeText: MRI of brain and spine was performed in this subject demonstrating cerebellar HB. Funduscopic evaluation of the right eye showed a well defined orange-red mass corresponding to a peripheral retinal HB of approximately 1 disc diameter associated with a prominent feeding artery and to a draining vein. FAG demonstrated hyperfluorescence of this retinal angioma as well as enlargement and tortuosity of retinal blood vessels.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Family pedigree (Figure 1(a))

      Variant: p.R82P (c.245G>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 526675, https://www.ncbi.nlm.nih.gov/clinvar/variation/526675/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: R82P (c.245G>C)

      MultipleGeneVariants: N/A

    1. Interventional case report of a 28-year-old patient with multiple and large retinal capillary hemangiomas underwent PPV combined with relaxing retinectomy.

      PatientID: 1 (case)

      KindredID: 1

      Case: F, 30Y0M, Vietnamese

      DiseaseAssertion: VHL

      FamilyInfo: None - The diagnosis of VHL had not been established in her parents or her relatives, who lived in Vietnam without further evaluation.

      CasePresentingHPOs: HP:0009711; HP:0001737 (retinal capillary hemangioma; pancreatic cysts)

      CaseHPOFreeText: At 28Y presented with multiple retinal capillary hemangioma (complicated tractional retinal detachment and multiple large angiomas) and multiple pancreatic cysts. Underwent PPV combined with relaxing retinectomy.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167W (c.499C>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 2218, https://www.ncbi.nlm.nih.gov/clinvar/variation/2218/

      CAID: N/A

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/3-10191506-C-T

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167W (c.499C>T)

      MultipleGeneVariants: N/A

    1. 16 patients

      PatientID: 3

      KindredID: 3

      Case: Sex Unknown, 38Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: Patient had family history of VHL disease. The patient’s aunt and her son had the same mutation, but no clinical manifestations. The patient’s mother, another aunt and her son had hemangioblastomas at age 30, 33, and 32, respectively, but died prior to genetic testing could be performed.

      CohortInfo: 16 Chinese patients clinically diagnosed with VHL disease.

      CasePresentingHPOs: HP:0010797; HP:0005584; HP:0001732 (hemangioblastoma; renal cell carcinoma; abnormality of the pancreas)

      CaseHPOFreeText: The patient presented with a hemangioblastoma at age 28, as well as renal cell carcinoma at age and abnormality of the pancreas at age 38.

      CaseNotHPOs: HP:0009711, HP:0002666, HP:0030393, (retinal capillary hemangioma, pheochromocytoma, endolymphatic sac tumor)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.N90I (c.269A>T)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223172, https://www.ncbi.nlm.nih.gov/clinvar/variation/223172/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant; transversion

      CivicName: N90I (c.269A>T)

      MultipleGeneVariants: N/A

    1. GroupID: 8

      Case: 37Y0M, Sex Unknown, Ethnicity Unknown

      DiseaseAssertion: assumed VHL

      FamilyInfo: 1 of the 573 patients discussed in this paper were found to have this variant. This mutation was found in 1 VHL family with a single patient.

      CasePresentingHPOs: HP:0005584; HP:0009711; HP:0006880 (renal cell carcinoma; retinal capillary hemangioma; cerebellar hemangioblastoma)

      CaseHPOFreeText: patient had retinal angiomas diagnosed at 28Y, cerebellar hemangioblastomas diagnosed at 22Y, and renal cell carcinoma diagnosed at 37Y.

      CaseNotHPOs: HP:0002666 (pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Supplementary Table S1.

      Variant: p.R177* (c.529A>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 625258 https://www.ncbi.nlm.nih.gov/clinvar/variation/625258/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: R177* (c.529A>T)

      MultipleGeneVariants: N/A

  3. Oct 2026
    1. PatientID: 104

      KindredID: 35

      Case: F, 28Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The proband, patient 104, presented with multiple pancreatic cysts/tumors at age 27. Their sister, patient 105 presented with pancreatic cysts/tumors at age 28. Their mother presented with a CNS hemangioblastoma at 45 but passed away before diagnosis/genetic testing.

      CasePresentingHPOs: HP:0001737; HP:0001732 (Pancreatic cysts, Abnormality of the pancreas)

      CaseHPOFreeText: The proband's sister presented with multiple pancreatic cysts/tumors at age 28.

      CaseNotHPOs: HP:0005584; HP:0002666; HP:0009711; HP:0010797 (Renal cell carcinoma, Pheochromocytoma, Retinal capillary hemangioma, Hemangioblastoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This cohort was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.Y98S (c.293A>C)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 219160; https://www.ncbi.nlm.nih.gov/clinvar/variation/219160/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: Y98S (c.293A>C)

      MultipleGeneVariants: N/A

    2. PatientID: 127

      KindredID: 47

      Case: F, 28Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0010797; HP:0005584; HP:0001737; HP:0001732; HP:0009711 (Hemangioblastoma, Renal cell carcinoma, Pancreatic cysts, Abnormality of the pancreas, Retinal capillary hemangioma)

      CaseHPOFreeText: The proband presented at age 25 with a CNS hemangioblastoma, retinal angioma, and renal cell carcinoma, and presented with multiple pancreatic cysts/tumors at age 28.

      CaseNotHPOs: HP:0002666 (Pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This kindred was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.E134_V142del (c.402_428del)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: Variant listed in the paper as c.402-428delATTATTTGTGCCATCTCTCAATGTTGA, p.Glu134Aspfs*72. Listed protein change does not match deletion. Deletion is in-frame and should not lead to a frame shift. Variant updated in this annotation based on protein change listed in ClinGen/ listed on Variant Validator for c.402-428del.

      ClinVarID: N/A

      CAID: CA2573320387, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_caid?caid=CA2573320387

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: inframe_deletion

      CivicName: E134_V142del (c.402_428del)

      MultipleGeneVariants: N/A

    3. PatientID: 175

      KindredID: 69

      Case: F, 35Y0M, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: The male proband, patient 143, was diagnosed with renal cell carcinoma and multiple pancreatic cysts/tumors at age 33. His mother, who was not confirmed with the mutation, had a CNS hemangioblastoma at 30, retinal angioma at 54, and renal cell carcinoma at 50. His sister had a CNS hemangioblastoma at 28, and renal cell carcinoma/ multiple pancreatic cysts/tumors at 35. His niece, who was not confirmed with the mutation, had a CNS hemangioblastoma at age 12. His aunt had a CNS hemangioblastoma at 37, retinal angioma at 45, and renal cell carcinoma at 53. The son of his aunt was asymptomatic at the time of analysis.

      CasePresentingHPOs: HP:0005584; HP:0001737; HP:0001732; HP:0010797 (Renal cell carcinoma, Pancreatic cysts, Abnormality of the pancreas, Hemangioblastoma)

      CaseHPOFreeText: The proband's sister presented with a CNS hemangioblastoma at age 28 and renal cell carcinoma and multiple pancreatic cysts/tumors at age 35.

      CaseNotHPOs: HP:0002666; HP:0009711 (Pheochromocytoma, Retinal capillary hemangioma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: This patient was also published in a later paper by Wang et al., 2018 (PMID: 29330336).

      SupplementalData: Patient and family genotype-phenotype information is listed in Supplementary Table 1.

      Variant: p.C162W (c.486C>G)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: 223227; https://www.ncbi.nlm.nih.gov/clinvar/variation/223227/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: missense_variant;transversion

      CivicName: C162W (c.486C>G)

      MultipleGeneVariants: N/A

    1. PatientID: 1 (Proband)

      KindredID: 12

      Case: M, 57Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: This patient had a father that was assumed to have the c.406T>C germline mutation of the VHL gene but was not confirmed genetically. His father presented with renal cell carcinoma and died at 47Y.

      CasePresentingHPOs: HP:0010797; HP:0009711; HP:0000077; HP:0001732 (Hemangioblastoma, Retinal capillary hemangioma, Abnormality of the kidney, Abnormality of the pancreas)

      CaseHPOFreeText: This patient presented with CNS hemangioblastoma (37Y), retinal angioma (27Y) and renal and pancreatic cyst or tumor (unspecified) (28Y).

      CaseNotHPOs: HP:0002666; HP:0005584 (Pheochromocytoma, Renal cell carcinoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Supplementary Table 1.

      Variant: p.S65P (c.193T>C)

      LegacyVariant: c.406T>C

      CaseProblemVariantFreeText: N/A

      ClinVarID: 547829, https://www.ncbi.nlm.nih.gov/clinvar/variation/547829/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Variant reference sequence is unclear in the current paper. After consulting the SickKids patient database, and finding the protein change to be recorded as: p.Ser65Pro, it was concluded that the current paper reported the cDNA change according to the legacy reference sequence (AF010238.1) and was mapped to c.193T>C (NM_000551.3).

      MutationType: missense_variant;transition

      CivicName: S65P (c.193T>C)

      MultipleGeneVariants: N/A

    2. PatientID: 6 (Mother)

      KindredID: 18

      Case: F, 75Y0M, Ethnicity Unknown

      DiseaseAssertion: Assumed VHL

      FamilyInfo: 11 members of this family tested positive for the c.712C>T/c.499C>T germline variant of the VHL gene. 14 members of this family were assumed to carry this variant due to family history/personal medical history. Members of this family range from asymptomatic to multi-organ involvement (pheochromocytoma, pancreatic and renal cysts/tumors and hemangioblastomas). The family was previously reported in PMID 3942913.

      CasePresentingHPOs: HP:0010797; HP:0009711 (Hemangioblastoma, Retinal capillary hemangioma)

      CaseHPOFreeText: This patient presented with CNS hemangioblastoma (54Y) and retinal angioma (28Y).

      CaseNotHPOs: HP:0005584; HP:0000077; HP:0001732; HP:0002666 (Renal cell carcinoma, Abnormality of the kidney, Abnormality of the pancreas, Pheochromocytoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: 3942913 (some members of this family are previously reported (phenotypes only) but unable to match patients across papers with confidence)

      SupplementalData: Supplementary Table 1.

      Variant: N/A

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVarID: N/A

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: Authors state that the c.712C>T germline familial variant of the VHL gene in this patient is “inferred from the family”. No genetic testing was done on this patient to confirm this. Being that this familial variant is out of bound with respect to the NM_000551.3 reference sequence, it was concluded that this variant is noted in the Latif et al. (1993) reference and was translated to c.499C>T (NM_000551.3).

      MutationType: N/A

      CivicName: N/A

      MultipleGeneVariants: N/A

    1. GroupID: 18

      Case: 28Y0M, Sex Unknown, Ethnicity Unknown

      DiseaseAssertion: retinal capillary hemangioma

      FamilyInfo: 1 of the 573 patients discussed in this paper were found to have this variant. This mutation was found in 1 VHL family with a single patient.

      CasePresentingHPOs: HP:0009711 (retinal capillary hemangioma)

      CaseHPOFreeText: patient had retinal angiomas diagnosed at 28Y

      CaseNotHPOs: HP:0005584; HP:0002666; HP:0006880 (renal cell carcinoma; pheochromocytoma; cerebellar hemangioblastoma)

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: Supplementary Table S1.

      Variant: p.R113Efs*46 (c.337del)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: N/A

      CAID: CA432420675 http://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.337del

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift_variant

      CivicName: R113FS (c.337delC)

      MultipleGeneVariants: N/A

    1. A female patient presented with VHL disease at age 16, when a symptomatic left adrenal pheochromocytoma was diagnosed and removed laparoscopically. At age 28, a cystic cerebellar hemangioblastoma was removed. Molecular genetic testing revealed the mutation VHL c.500 G > A (p. R167Q).In 2010, she was admitted to the Freiburg Preventive Medicine Center. Baseline MRI detected multiple intraspinal hemangioblastomas associated with tumor cysts. Abdominal MRI also showed a 5.6 × 5.4 cm solid tumor in the pancreatic tail that was richly vascularized

      PatientID: 3

      KindredID: 3

      Case: F, 28Y0M, German

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0006748, HP:0006880, HP:0009713, HP:0030405, HP:0010302 (Adrenal pheochromocytoma, cerebellar hemangioblastoma, spinal hemangioblastoma, pancreatic endocrine tumour, spinal cord tumor)

      CaseHPOFreeText: At age 16 she presented with a left adrenal pheochromocytoma which was removed laparoscopically. At age 28, a cystic cerebellar hemangioblastoma was removed. In 2010, she was admitted to the Freiburg Preventive Medicine Center. Baseline MRI detected multiple intraspinal hemangioblastomas associated with tumor cysts. Abdominal MRI also showed a 5.6 × 5.4 cm solid tumor in the pancreatic tail that was richly vascularized. Three of eleven lymph nodes showed metastases.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R167Q (c.500G>A)

      LegacyVariant: N/A

      CaseProblemVariantFreeText: N/A

      ClinVar: 2216 https://www.ncbi.nlm.nih.gov/clinvar/variation/2216/

      CAID: N/A

      gnomAD: 0.000003977 https://gnomad.broadinstitute.org/variant/3-10191507-G-A

      VariantEvidence: N/A

      MutationType: missense_variant;transition

      CivicName: R167Q (c.500G>A)

      MultipleGeneVariants: N/A

    1. 5

      PatientID: I-2

      KindredID: 1

      Case: F, Age Unknown, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: In the patient’s 12 member Chinese family, 7 members were found to carry the NM_000551.3:c.114delC mutation. Five had manifestations of CNS hemangioblastoma, and three of the five were deceased. The other two members found to carry the mutation were asymptomatic, although the paper states that this is likely due to their young age.

      CasePresentingHPOs: HP:0010797 (Hemangioblastoma)

      CaseHPOFreeText: The patient is deceased. The paper implies that the mutation was confirmed through stored tumour tissue.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.G39Afs*28(c.114delC)

      LegacyVariant: p.G39Afs*28(c.327delC)

      ClinVarID: N/A

      CAID: CA2573047816, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_canonicalid?canonicalid=CA2573047816

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift_variant

      CivicName: G39fs(c.114delC)

      MultipleGeneVariants: N/A

    2. healthy

      PatientID: III-5

      KindredID: 1

      Case: M, Age Unknown, Chinese

      DiseaseAssertion: Asymptomatic

      FamilyInfo: In the patient’s 12 member Chinese family, 7 members were found to carry the NM_000551.3:c.114delC mutation. Five had manifestations of CNS hemangioblastoma, and three of the five were deceased. The other member found to carry the mutation were asymptomatic, although the paper states that this is likely due to their young age.

      CasePresentingHPOs: N/A

      CaseHPOFreeText: The paper states that the patient is young, but no specific age is given.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.G39Afs*28(c.114delC)

      LegacyVariant: p.G39Afs*28(c.327delC)

      ClinVarID: N/A

      CAID: CA2573047816, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_canonicalid?canonicalid=CA2573047816

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift_variant

      CivicName: G39Afs(c.114delC)

      MultipleGeneVariants: N/A

    3. 5

      PatientID: III-3

      KindredID: 1

      Case: M, Age Unknown, Chinese

      DiseaseAssertion: VHL

      FamilyInfo: In the patient’s 12 member Chinese family, 7 members were found to carry the NM_000551.3:c.114delC mutation. Five had manifestations of CNS hemangioblastoma, and three of the five were deceased. The other two members found to carry the mutation were asymptomatic, although the paper states that this is likely due to their young age.

      CasePresentingHPOs: HP:0010797 (Hemangioblastoma)

      CaseHPOFreeText: The patient suffered from progressive severe neck pain and numbness of the left arm for 6 months. The patient was initially treated with opioids and antiinflammatory medications and wore rigid neck collars. Despite intense conservative therapy, the patient experienced inadequate pain relief and underwent resection of CNS hemangioblastoma.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.G39Afs*28(c.114delC)

      LegacyVariant: p.G39Afs*28(c.327delC)

      ClinVarID: N/A

      CAID: CA2573047816, https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/by_canonicalid?canonicalid=CA2573047816

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift_variant

      CivicName: G39Afs(c.114delC)

      MultipleGeneVariants: N/A

    1. PatientID: 8

      KindredID: 8

      Case: M,35Y0M, Ethnicity Unknown

      DiseaseAssertion: VHL

      FamilyInfo: N/A

      CohortInfo: Thirteen patients with a supratentorial hemangioblastoma.

      CasePresentingHPOs: HP:0010797 (hemangioblastoma)

      CaseHPOFreeText: The patient had a meckel cave hemangioblastoma at age 28. The patient had a papillary edema and pituitary stalk hemangioblastoma at age 34. The patient died of VHL disease.

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.R161* (c.481C>T)

      CaseProblemVariantFreeText: N/A

      LegacyVariant: N/A

      ClinVarID: 2217 https://www.ncbi.nlm.nih.gov/clinvar/variation/2217/

      CAID: N/A

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: stop_gained

      CivicName: R161* (c.481C>T)

      MultipleGeneVariants: N/A

    1. B1 Spinal 28 c.582_589delGACACAC N/A 5 y 10 m 

      PatientID: B1

      KindredID: 1

      Case: Sex Unknown, 28Y0M, Ethnicity Unknown

      DiseaseAssertion: Assumed VHL

      FamilyInfo: No testing

      CasePresentingHPOs: HP:0009713, HP:0000107, HP:0001737 (spinal hemangioblastoma, renal cyst, pancreatic cyst)

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: no other clinical features were found after the cerebellar hemangioblastoma during 5 years 10 months of follow-up

      CasePreviousTesting: N/A

      PreviouslyPublished: N/A

      SupplementalData: N/A

      Variant: p.T124Mfs*33 (c.369_375del)

      LegacyVariant: c.582_589delGACACAC

      ClinVarID: N/A

      CAID: CA913189240 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvsOrDescriptor=NM_000551.3%3Ac.369_375del

      gnomAD: N/A

      VariantEvidence: N/A

      MutationType: minus_1_frameshift_variant

      CivicName: T124Mfs*33(c.369_375del)

      MultipleGeneVariants: N/A

    1. They went up through the maze of parked and cruising cars to the bright-lit, fly-infested restaurant, their faces pleased and expectant as if they were entering a sacred building that loomed up out of the night to give them what haven and blessing they yearned for.

      The specific description of the restaurant makes me feel uncomfortable , especially the “fly-invested” make me confusing that why Connie and their friend would like to go there

    2. the music was always in the background, like music at a church service; it was something to depend upon.

      I think the comparison to a church service is interesting because church is usually associated with safety, faith, and guidance, while the music Connie listens to eventually becomes connected to something dangerous.

  4. Sep 2026
  5. Apr 2026
    1. I am a man who, from his youth upwards, has been filled with a profound conviction that the easiest way of life is the best.

      This sentence is interesting because it presents the idea that the easiest way of life is the best, which contrasts with the modern belief that success requires hard work and struggle. It makes me reflect on whether a simple and peaceful life might actually lead to greater happiness than constant ambition and pressure.

    1. Urgent treatment for neoplasm consists of (1) cautious use of intravenous diuretics and (2) mediastinal irradiation, starting within 24 hours, with a treatment plan designed to give a high daily dose of radiation but a short total course of therapy to rapidly shrink the local tumor. Intensive radiation therapy combined with chemotherapy will palliate the process in up to 90% of patients. In patients with a subacute presentation, radiation therapy alone usually suffices. Chemotherapy is added if lymphoma or small-cell carcinoma is diagnosed

      endovascular stenting emerging as first-line therapy for rapid symptom relief, while definitive treatment targets the underlying cause

      Glucocorticoids (dexamethasone 4 mg every 6 hours) are commonly prescribed but lack robust supporting data; they may be more beneficial in lymphoma or thymoma and as prophylaxis against radiation-induced edema. [2-4] Importantly, SVC syndrome is no longer considered a medical emergency except in rare cases with life-threatening cerebral edema, laryngeal edema, or altered mental status. When thrombosis is present, catheter-directed thrombolysis or aspiration thrombectomy should be performed within 2-5 days of symptom onset before thrombus organization occurs. [3] The role of long-term anticoagulation after stenting remains unclear, though it is standard when significant thrombosis is present The American College of Chest Physicians recommends obtaining histologic diagnosis before treatment in suspected lung cancer cases, as stenting does not interfere with tissue diagnosis. [2] For small cell lung cancer (SCLC), chemotherapy alone is recommended as first-line treatment given rapid response rates. [2] For non-small cell lung cancer (NSCLC), radiation therapy and/or stent insertion are recommended, with response rates of 59% for chemotherapy and 63% for radiation therapy. [2] Patients with chemotherapy- or radiation-refractory disease should receive vascular stents For device-related thrombosis (catheters, pacemakers), catheter removal should be considered in conjunction with anticoagulation. [4] Endovascular therapy is first-line for device-related obstruction, while surgical bypass may be preferred for mediastinal fibrosis. [7] Both approaches show good mid-term patency, though secondary interventions are common (approximately 27-28%

    Tags

    Annotators

    URL

  6. Dec 2025
  7. Oct 2025
    1. that I might hearken to it with the more satisfaction, I ceased my labours and sat down upon the bones.

      It is troubling that Montresor shows no hesitation or guilt while listening to Fortunato’s cries. His enjoyment of the sound of chains reveals his cruelty and the disturbing pleasure he takes in revenge.

    2. I had scarcely laid the first tier of my masonry when I discovered that the intoxication of Fortunato had in a great measure worn off. The earliest indication I had of this was a low moaning cry from the depth of the recess. It was not the cry of a drunken man. There was then a long and obstinate silence. I laid the second tier, and the third, and the fourth; and then I heard the furious vibrations of the chain. The noise lasted for several minutes, during which, that I might hearken to it with the more satisfaction, I ceased my labours and sat down upon the bones. When at last the clanking subsided, I resumed the trowel, and finished without interruption the fifth, the sixth, and the seventh tier. The wall was now nearly upon a level with my breast. I again paused, and holding the flambeaux over the mason-work, threw a few feeble rays upon the figure within.

      It is surprising that Fortunato suddenly regains his awareness, but it is already too late for him to escape. Montresor’s calm reaction to his desperate struggle is unexpected and chilling.

    1. Looking as if she were alive. I call That piece a wonder, now: Frà Pandolf's hands

      It’s interesting how he begins so calmly, just describing a painting — but there’s already something unsettling underneath. It makes me curious about what really happened to the Duchess.

    2. Never to stoop. Oh, sir, she smiled, no doubt, Whene'er I passed her; but who passed without Much the same smile? This grew; I gave commands;

      I was shocked by how easily he admits giving “commands”, as if ordering his wife’s death was just another act of pride. He sounds more offended by his wife’s kindness.

    1. While there are many different roles on a college campus that could be included in this list,advisors deserve a special place because they are crucial to your success; they are also the first place to gowhen a student has an issue. Some advisors spend considerable time with students to help them choose amajor and create a schedule each semester that will enable them to graduate. Others serve as a soundingboard for students who are struggling in a class and deciding whether or not to drop. Developing arelationship with your advisor has obvious benefits: They get to know what your goals are and can helpyou refine them

      I used to think that the job of college advisors was only to help with class schedules, but now I see that they also give emotional support and guidance when students face problems. It’s interesting to know that building a relationship with an advisor can really make a big difference in college life.

    2. John sinks down in his seat, afraid she is going to ask him questions as well. He pulls out his phone and looksthrough social media to keep her from bothering him. As other students enter the class, some quiet andothers talkative, John wonders if he will have to interact with them. Even though he has not met many peopleyet–and certainly has not had any deep conversations with anyone–he feels anxious about having to get toknow strangers and feels most comfortable keeping to himself at least fo

      This situation shows how easily anxiety can keep someone from connecting with others. It’s sad that John feels the need to hide behind his phone instead of giving himself a chance to meet new people. It reminds me how difficult social situations can be when fear takes over, and how important it is to slowly build confidence to open up.

    3. When you are feeling calm and nourished, you are going to look forward to your day, and despite howbusy it is, you will prioritize time with friends and family. If you don’t take care of and learn to love yourself,you will never be able to bring your best self to any relationshi

      When we take care of ourselves, we have more energy and positivity to share with others. It made me realize that loving yourself is the first step to loving others. I used to think taking care of myself was less important than caring for others, but now I see how closely they are connected.

  8. Jun 2025
  9. May 2025
    1. Ende April 2025 forderte der EU-Energiekommissar Dan Jørgensen erneut mehr LNG-Importe aus den USA, um die Abhängigkeit von russischem Gas zu verringern. Die EU plant, bis 2027 kein russisches Gas mehr zu beziehen. Kritiker, wie Greenpeace, warnen jedoch vor den höheren Kosten und Klimaschäden von LNG und fordern stattdessen Investitionen in erneuerbare Energien.

      [Zusammenfassung mit Mistral generiert] https://taz.de/Unabhaengigkeit-von-russischem-Gas/!6082106/

  10. Apr 2025
    1. Of the 10,504 locations reviewed, providers should not have been listed at 33.14% (3,481) of thelocations (2,088 + 1,393, as shown in Table 5) either because the provider did not work at thelocation or because the provider did not accept the plan at the location. In 1,393 of theseinstances, the provider should not have been listed at any of the locations in the directory. Therewere 690 phone numbers that were wrong or disconnected and 364 incorrect addresses. Finally,there were 221 instances in which the provider was found not to be accepting new patients,although the directory indicated that the provider was accepting new patients. Table 5 provides abreakdown of deficiencies identified by CMS during the review process.

      This is a review of Medicare Advantage Plans provider directories. It details multiple failings in these provider directories. NPPES is not directly mentioned, but is likely the source of the various business address problems in the data.

    1. Disease: Von-willebrand Disease (Type 2A)

      Patient: 50 yo female

      Variant: VWF NM_000552.5 c:4232_4249del p.(Val411_Ile416del), Exon 28, heterozygous variant

      According to this paper, ACMG-AMP guidelines for interpreting this variant resulted in classification of likely pathogenic

      Phenotypes: increased bruising, fatigue, recurrent sinusitis, menorrhagia, neutropenia, anaemia. Reduction in high-molecular-weight multimers

      Family: segregation analysis showed two affected family members had the variant and two unaffected family members did not have variant.

      Note: Patient also has diagnosed Acute Myeloid Leukaemia (AML) NM_000546.6(TP53):c704A>G p.(Asn235Ser), listed as VUS and found by NGS

  11. Mar 2025
  12. southtexascollege.blackboard.com southtexascollege.blackboard.com
    1. Just so much honor, when thou yield’st to me, Will waste, as this flea’s death took life from thee.

      In connection to line 27, it seems what seems to be getting lost is the listener's honor. The speaker (?) seems to connect this, comparing the fear of loosing her honor in connection to the flea's death. By saying this, the speaker goes on to push, saying that similar to the flea's death having no consequence, their will be no consequence to them being intimate.

    1. Überblicksartikel von 2019 zu den Angriffen auf die Wissenschaft während der ersten Trump-Regierung und ihre kurz- und langfristigen Folgen. Forschungen zur Klimakrise und öffentlichen Gesundheit wurden behindert, weil sie den Interessen der fossilen Industrien schaden. Der Kampf gegen Foschung, die Interessen bestimmter Unternehmen und Branchen bedroht, ging aber weit über die Klimathematik hinaus und dient u.a. auch der Chemie- und Agroindustrien. Zu den Maßnahmen gehörten: - Beendigung von Forschungsprojekten - Abbau des Einflusses von Wissenschaftler:innen auf regulatorische Entscheidungen - Verhinderung von öffentlichen Stellungnahmen von Wissenschaftler:innen - Behinderung von Forschungen zum menschengemachten Klimawandel - Vorschreiben erwünschter Forschungsergebnisse - Overruling von Experten durch politische Funktionäre bei Begutachtungen und Regulierungen - Einstellungsstopps und Entlassungen - Entfernung bestimmter Wissenschaftler:innen aus Beratungsgremien - Verbot der Berücksichtigung bestimmter Wissenschaftstypen bei Regulierungen - Druck auf Forschende, unwissenschaftliche Aussagen des Präsidenten zu unterstützen - Schließung von Forschungszentren und -büros und Auflösung von Ausschüssen - Umsiedlungen von Behörden und Forschungseinrichtungen in unattraktive Gegenden

      https://www.nytimes.com/2019/12/28/climate/trump-administration-war-on-science.html

  13. Feb 2025
  14. Jan 2025
    1. Es wird erwartet, dass der britische Premierminister Sunak in seiner nächsten Regierungserklärung eine Ausdehnung der Öl- und Gasförderung in der Nordsee und Maßnahmen zum Schutz von Autofahren, z.B. vor Geschwindigkeitsbegrenzungen in Städten, ankündigt. Durch seine anti-Umweltpolitik will sich Sunak von der Labour-Opposition absetzen, die im Augenblick in Großbritannien in Meinungsumfragen weit vor den Tories liegt. https://www.theguardian.com/politics/2023/oct/28/rishi-sunak-to-double-down-on-anti-green-policies-in-kings-speech

  15. Dec 2024
  16. Nov 2024
  17. Oct 2024
    1. Disease: Von-willebrand Disorder, type 1

      Patient 1 Variant: VWF NM_000552.5: c.4135C>T p.(Arg1379Cys) Exon 28

      Family: History not mentioned

      Patient 1 phenotype: near normal VWF:Ag and WVF:RCo levels RIPA within normal range Platelet VWF levels were normal normal pattern for multimeric analysis of plasma Slightly reduced VWF levels

      In silico predictions available:

      I-Mutant 3.0 value = -1.36 PYMOL prediction = substitution of ARG 1379 with a cysteine results in the loss of hydrogen bonds with Lys1407 and Lys1408, predicted change in secondary structure of A1 domain

  18. Sep 2024
    1. Addressed an issue where weapons other than Shotguns could be affected by the Enforcer perk in specific circumstances.

      Thrown weapons would benefit due to "Enforcer" [PERK:00322354] checked for Subject.WornHasKeyword = WeaponTypeShotgun instead of Subject.HasKeyword = WeaponTypeShotgun

    1. Addressed an issue where weapons other than Shotguns could be affected by the Enforcer perk in specific circumstances.

      Thrown weapons would benefit due to "Enforcer" [PERK:00322354] checked for Subject.WornHasKeyword = WeaponTypeShotgun instead of Subject.HasKeyword = WeaponTypeShotgun

  19. Aug 2024
  20. May 2024
    1. Unmittelbar vor der COP28 wurde bekannt, dass die Adnoc, die staatliche Ölgesellschaft Abu Dhabis, ein Anbot vorbereitet, um für 11 Mrd. USD die deutsche Firma Wintershall Dea von der BASF zu übernehmen. Die Wintershall Dea hat eine Schlüsselrolle für das Gasgeschäft in Deutschland und Norwegen, u.a. wegen der neuen LNG-Infrastruktur. Chef der Adnoc ist Sultan Al Jaber, der Präsident der COP28. Zum HIntergrund der Nachricht gehören der gemeinsame Ausbau der Petrochemie-Sparte mit Borealis und das Engagement der Adnoc im zukünftigen Wasserstoff- und CCS-Geschäft https://www.reuters.com/breakingviews/adnoc-german-oil-deal-has-bad-timing-good-logic-2023-11-28/

    1. Neuer Bericht des Global Energy Monitor zur fossilen Expansion. 45 Öl- und Gasprojekte sind vollständig in Gang gesetzt worden seit die IEA 2021 festgestellt hat, dass weitere Öl- und Gasprojekte die Einhaltung des 1,5°-Ziels unmöglich machen. Sie werden zu 16 Milliarden Barrel Öl-Äquivalent Förderung führen. Bis 2030 will die Ölindustrie die Förederung aus insgesamt 64 neuentdeckten Lagern auf 31 Mrd, Barrel steigern. Die USA ist bei der Entwicklung führend, gefolgt von Guyana. https://www.theguardian.com/environment/2024/mar/28/oil-and-gas-fossil-fuels-report

      Bericht: https://globalenergymonitor.org/report/drilling-deeper-2024-global-oil-gas-extraction-tracker/

    1. Die rohölproduktion in den USA wird in diesem Jahr ein Rekord-Hoch erreichen Etwa 25% der US-Emissionen werden durch Öl und Gas verursacht, das auf Bundesterritorien gefördert wird. Die New York Times zeigt ausgehend von einem Beispiel im Golf von Mexiko, warum es angesichts der Mehrheitsverhältnisse in Repräsentantenhaus und Senat und des konservativen obersten Gerichtshofs für die für die Biden-Administration extrem schwierig ist, die Zusage, dort keine weiteren Bohrungen zuzulassen, umzusetzen.

      https://www.nytimes.com/2023/09/28/climate/biden-drilling-leases.html

  21. Apr 2024
  22. Mar 2024
    1. In einem Interview mit dem Guardian spricht sich der noch amtierende US-Klimabeauftragte John Kerry scharf gegen Desinformation und Demagogie aus. In einer Phase, in der es in der Politik um den Kampf um Fortschritt oder den Kampf um Verzögerung gehe, würden sie gezielt eingesetzt. Die Klimapolitik der Biden-Administration orientiere sich ausschließlich an der Wissenschaft. Käme es zu dem aktuell von vielen betriebenen Rückschlag in der Klimapolitik, wäre eine Katastrophe für Milliarden und globale Unsicherheit die Folge. https://www.theguardian.com/environment/2024/feb/28/populism-imperilling-global-fight-against-climate-breakdown-says-john-kerry

  23. Feb 2024
    1. Michel Forst, UN-Berichterstatter zur Aarhus-Konvention, hat die europäischen Regierungen aufgefordert, Klima-Aktivist:innen zu unterstützen statt sie zu kriminalisieren. Die zunehmende Repression gefährde das Erreichen der Pariser Klimaziele und Demokratie und Menschenrechte in Europa. Forst erwartet, dass Protest und direkte Aktion zunehmen, weil die aktuelle Politik vieler europäischer Regierungen die wissenschaftlichen Erkenntnisse zu globaler Erhitzung, Biodiversitätsverlust und Umweltverschmutzung nicht respektiert. https://www.theguardian.com/environment/2024/feb/28/european-nations-must-end-repression-of-peaceful-climate-protest-says-un-expert

      Positionspapier von Michel Forst: https://unece.org/sites/default/files/2024-02/UNSR_EnvDefenders_Aarhus_Position_Paper_Civil_Disobedience_EN.pdf

  24. Jan 2024
  25. Dec 2023
  26. Nov 2023
  27. Oct 2023
    1. Part I: Inventors

      I've come to think that the purpose of part 1 of the book is part rhetorical device (ethos). David Lipsky is using it to build up some credibility as a writer. He's covering topics that many are likely somewhat knowledgeable about, but is adding some additional color, details, and information which most surely don't know. This has the effect of showing the depths to which he's researched the topics to be able to weave them into such a story.

      This will tend to pay off as he begins addressing the potentially more contentious (for some) material in the climate crisis section.

    1. There are several occasions where the massebah is not associated with pagan worship. When the massebah is associated with the worship of Yahweh, the massebah is accepted as a valid expression of commitment to Yahweh.

      Massebah for pagan worship: - Exodus 23:24 (https://hypothes.is/a/r3m5QmyDEe6SC8eLYcJE1Q) - Hosea 10:1 (https://hypothes.is/a/4PK2GGyDEe6wZg_r2YpVCA ) - 2 Kings 18:4 - 2 Kings 23:14

      Massebah for worship of Yahweh: - Genesis 28:18 Jacob's pillow (https://hypothes.is/a/NF5p8Gx6Ee65Rg_J4tfaMQ)<br /> - Genesis 31:44-45 Jacob and Laban's covenant - Exodus 24:4 - Joshua 24:25-27

    1. Interview mit dem Agrarwissenschaftler Michael Succow zm Bodenschutz und zur Trinkwasserknappheit in Deutschland. In einigen Gebieten wird inzwschen kein Grundwasser mehr gebildet, fast durchgängig ist es chemisch kontaminiert. Succow plädiert für eine radikale Umstellung auf biologische Landwirtschaft und gegen den Anbau des wasserintensiven Mais zur Verfütterung an Rinder. https://www.derstandard.at/story/3000000187638/biologe-mais-duerfte-hier-ueberhaupt-nicht-angebaut-werden

    1. Die Umweltexpertin und Klima-Aktivistin Hoang Thi Minh wurde in Vietnam wegen angebllicher Steuerhinterziehung zu drei Jahren Haft verurteilt. Mindestens vier ähnliche Urteile sind bekannt. Unter dem Vorwurf der Steuehinterziehung wurde im September auch die prominente Umweltexpertin Ngo Thi To Nhien verhaftet. Zivilgesellschaftliches Engagement gegen die Klimakrise wird in Vietnam durchgehend kriminalisiert und verfolgt.https://taz.de/Klimaaktivistin-in-Vietnam-in-Haft/!5959470/

  28. Sep 2023
  29. Mar 2023
    1. Ki gépen száll fölébe, annak térkép e táj, s nem tudja, hol lakott itt Vörösmarty Mihály, annak mit rejt e térkép? gyárat s vad laktanyát, de nékem szöcskét, ökröt, tornyot, szelíd tanyát, az gyárat lát a látcsőn és szántóföldeket, míg én a dolgozót is, ki dolgáért remeg, erdőt, füttyös gyümölcsöst, szöllőt és sírokat, a sírok közt anyókát, ki halkan sírogat, s mi föntről pusztitandó vasút, vagy gyárüzem, az bakterház s a bakter előtte áll s üzen, piros zászló kezében, körötte sok gyerek, s a gyárak udvarában komondor hempereg; és ott a park, a régi szerelmek lábnyoma, a csókok íze számban hol méz, hol áfonya, s az iskolába menvén, a járda peremén, hogy ne feleljek aznap, egy kőre léptem én, ím itt e kő, de föntről e kő se látható, nincs műszer, mellyel mindez jól megmutatható.

      ez a rész egyetlen mondat, képzeletbeli párbeszéd zajlik Radnóti és egy bombázó repülőgép pilótája között. a költő érveket sorakoztat fel, miért ne pusztítsa el hazáját. a szerkesztési elv roppant egyszerű: a pilóta fentről szemláli a tájat; csak egy térképet lát, míg a költő lentről figyeli a tájat, látja az apró életképeket, melyek a térképet élettel töltik meg. a költő ellentétpárokkal dolgozik: háborús célpontok állnak szemben a békés mindennapok képével (vad laktanya - szelíd tanya; gyárat - dolgozót; gyárüzem - gyerek). a pusztítandó célpontok Radnóti számára a hazát jelentik, amelyet ismer és szeret. visszatérnek az első rész képei is: erdő, füttyös gyümölcsös, sírok közt anyóka, bakterház udvarán játszó gyermekek. végül személyes emlékeket idéz fel: szerelmeit, egy apró követ mely szerencsét hozott neki diák korában. egyszóval felidézi a még háború előtti szelíd és békés gyermek- és fiatalkorát. mindez fentről nem látható, de talán átérezhető

  30. Feb 2023
    1. Example 12: Controller in the EU uses a processor in the EU subject to third country legislationThe Danish Company X, acting as controller, engages Company Y established in the EU as a processoron its behalf. Company Y is a subsidiary of the third country parent Company Z. Company Y isprocessing the data of Company X exclusively in the EU and there is no one outside the EU, includingthe parent Company Z, who has access to the data. Additionally, it follows from the contract betweenCompany X and Company Y that Company Y shall only process the personal data on documentedinstructions from Company X, unless required to do so by EU or Member State law to which CompanyY is subject. Company Y is however subject to third country legislation with extraterritorial effect,which in this case means that Company Y may receive access requests from third country authorities.Since Company Y is not in a third country (but an EU company subject to Article 3(1) GDPR), thedisclosure of data from the controller Company X to the processor Company Y does not amount to atransfer and Chapter V of the GDPR does not apply. As mentioned, there is however a possibility thatCompany Y receives access requests from third country authorities and should Company Y comply withsuch request, such disclosure of data would be considered a transfer under Chapter V. Where CompanyY complies with a request in violation of the controller’s instructions and thus Article 28 GDPR,Company Y shall be considered an independent controller of that processing under Article 28(10)GDPR. In this situation, the controller Company X should, before engaging the processor, assess thesecircumstances in order to ensure that, as required by Article 28 GDPR, it only uses processors providingsufficient guarantees to implement appropriate technical and organisational measures so that theprocessing is in line with the GDPR, including Chapter V, as well as to ensure that there is a contract orlegal act governing the processing by the processor.

      Not a transfer until the USG triggers a request, in which case Company Y becomes an independent controller ... though who is the data being transferred to? The USG on compelled order?

  31. Nov 2022
  32. Sep 2022
  33. May 2022
  34. Aug 2021
  35. Jul 2021
  36. Mar 2021
    1. Results for individual PALB2 variants were normalized relative to WT-PALB2 and the p.Tyr551ter (p.Y551X) truncating variant on a 1:5 scale with the fold change in GFP-positive cells for WT set at 5.0 and fold change GFP-positive cells for p.Y551X set at 1.0. The p.L24S (c.71T>C), p.L35P (c.104T>C), p.I944N (c.2831T>A), and p.L1070P (c.3209T>C) variants and all protein-truncating frame-shift and deletion variants tested were deficient in HDR activity, with normalized fold change <2.0 (approximately 40% activity) (Fig. 1a).

      AssayResult: 6.6

      AssayResultAssertion: Normal

      StandardErrorMean: 0.8

    1. Most Suspected Brugada Syndrome Variants Had (Partial) Loss of Function

      AssayResult: 0.8

      AssayResultAssertion: Abnormal

      ReplicateCount: 23

      StandardErrorMean: 0.6

      Comment: This variant had loss of function of peak current (<10% of wildtype), therefore it was considered abnormal (in vitro features consistent with Brugada Syndrome Type 1). (Personal communication: A. Glazer)

  37. Feb 2021